Transfusion-transmitted Babesiosis in an Immunocompromised Patient: A Case Report and Review
Abstract Babesiosis is a tick- and transfusion-borne disease caused by intraerythrocytic Babesia parasites. In 2009, a 61-year-old Minnesota woman with chronic lymphocytic leukemia and a history of recent chemotherapy and numerous blood transfusions for gastrointestinal bleeding became febrile and a...
Gespeichert in:
Veröffentlicht in: | The American journal of medicine 2011-09, Vol.124 (9), p.800-805 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 805 |
---|---|
container_issue | 9 |
container_start_page | 800 |
container_title | The American journal of medicine |
container_volume | 124 |
creator | Wudhikarn, Kitsada, MD Perry, Elizabeth H., MD Kemperman, Melissa, MPH Jensen, Kathy A., MT(SSB) Kline, Susan E., MD, MPH |
description | Abstract Babesiosis is a tick- and transfusion-borne disease caused by intraerythrocytic Babesia parasites. In 2009, a 61-year-old Minnesota woman with chronic lymphocytic leukemia and a history of recent chemotherapy and numerous blood transfusions for gastrointestinal bleeding became febrile and anemic 12 days postsplenectomy. Babesia were visualized on blood smears, confirmed by polymerase chain reaction as B. microti . She developed respiratory failure despite initiation of clindamycin and quinine, and required 12 weeks of azithromycin and atovaquone before blood smear and polymerase chain reaction findings were negative. Serologic evidence of B. microti infection was identified in 1 associated blood donor and 1 other recipient of that donor's blood. Babesia infection can be asymptomatic or cause mild to fulminant disease resulting in multiorgan failure or death. Patients with advanced age, asplenia, or other immune compromise are at risk for severe babesiosis and may require prolonged treatment to eradicate parasitemia. Incidence of transfusion-transmitted babesiosis has increased over the past decade. |
doi_str_mv | 10.1016/j.amjmed.2011.03.009 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_893267867</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0002934311002476</els_id><sourcerecordid>884846165</sourcerecordid><originalsourceid>FETCH-LOGICAL-c571t-48331c3310005ab235ce3ca5b57566310969043e60eec3e83f4af52ccfb524513</originalsourceid><addsrcrecordid>eNqFkstq3TAQhkVpaU7TvkEpplCysqu77S4K6aGXQCChTXcFIctjkOvLiSQ35O075pwkkE0WQiPp0-if-UXIW0YLRpn-2Bd27EdoC04ZK6goKK2fkQ1TSuUl0_w52VBKeV4LKY7Iqxh7XNJa6ZfkiDNdCcHlhvy5CnaK3RL9POVpjUefErTZF9sAbkYfMz9ldsrOxnGZZjePuzCPPiJyaZOHKX3KTrOtjZD9hN0cErIthv883LwmLzo7RHhzmI_J729fr7Y_8vOL72fb0_PcqZKlXKIW5nCgPmUbLpQD4axqVKm0xu1a11QK0BTACahEJ22nuHNdo7hUTByTk31elHa9QEwGBToYBjvBvERT1YLrstLl02QlK6mZVki-f0T28xImLGNNV3Gl6hWSe8iFOcYAndkFP9pwaxg1q0umN3uXzOqSocKgBXjt3SH30qxnd5fubEHgwwGw0dmhQ1-cjw-cxJYxunKf9xxgd7HjwUSHljhofQCXTDv7p5Q8TuAGP3l88y_cQrwvmZnIDTW_1h-1fiiGXnFZavEfM5rExw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>893825595</pqid></control><display><type>article</type><title>Transfusion-transmitted Babesiosis in an Immunocompromised Patient: A Case Report and Review</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Wudhikarn, Kitsada, MD ; Perry, Elizabeth H., MD ; Kemperman, Melissa, MPH ; Jensen, Kathy A., MT(SSB) ; Kline, Susan E., MD, MPH</creator><creatorcontrib>Wudhikarn, Kitsada, MD ; Perry, Elizabeth H., MD ; Kemperman, Melissa, MPH ; Jensen, Kathy A., MT(SSB) ; Kline, Susan E., MD, MPH</creatorcontrib><description>Abstract Babesiosis is a tick- and transfusion-borne disease caused by intraerythrocytic Babesia parasites. In 2009, a 61-year-old Minnesota woman with chronic lymphocytic leukemia and a history of recent chemotherapy and numerous blood transfusions for gastrointestinal bleeding became febrile and anemic 12 days postsplenectomy. Babesia were visualized on blood smears, confirmed by polymerase chain reaction as B. microti . She developed respiratory failure despite initiation of clindamycin and quinine, and required 12 weeks of azithromycin and atovaquone before blood smear and polymerase chain reaction findings were negative. Serologic evidence of B. microti infection was identified in 1 associated blood donor and 1 other recipient of that donor's blood. Babesia infection can be asymptomatic or cause mild to fulminant disease resulting in multiorgan failure or death. Patients with advanced age, asplenia, or other immune compromise are at risk for severe babesiosis and may require prolonged treatment to eradicate parasitemia. Incidence of transfusion-transmitted babesiosis has increased over the past decade.</description><identifier>ISSN: 0002-9343</identifier><identifier>EISSN: 1555-7162</identifier><identifier>DOI: 10.1016/j.amjmed.2011.03.009</identifier><identifier>PMID: 21683324</identifier><identifier>CODEN: AJMEAZ</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Anemia ; Anti-Bacterial Agents - therapeutic use ; Antimalarials - therapeutic use ; Antineoplastic Agents - adverse effects ; Antineoplastic Agents - therapeutic use ; Babesia ; Babesia microti ; Babesiosis - drug therapy ; Babesiosis - immunology ; Babesiosis - transmission ; Biological and medical sciences ; Blood transfusions ; Clindamycin - therapeutic use ; Drug Therapy, Combination ; Female ; General aspects ; Hemovigilance ; Humans ; Immunocompromised Host - immunology ; Immunocompromised hosts ; Immunodeficiencies ; Immunodeficiencies. Immunoglobulinopathies ; Immunopathology ; Internal Medicine ; Leukemia ; Leukemia, Lymphocytic, Chronic, B-Cell - immunology ; Leukemia, Lymphocytic, Chronic, B-Cell - therapy ; Medical sciences ; Middle Aged ; Opportunistic Infections - drug therapy ; Opportunistic Infections - immunology ; Opportunistic Infections - transmission ; Parasites ; Parasitic diseases ; Polymerase chain reaction ; Quinine - therapeutic use ; Respiratory Insufficiency - immunology ; Splenectomy ; Transfusion Reaction ; Transfusion-transmitted babesiosis ; Womens health</subject><ispartof>The American journal of medicine, 2011-09, Vol.124 (9), p.800-805</ispartof><rights>Elsevier Inc.</rights><rights>2011 Elsevier Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Sequoia S.A. Sep 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c571t-48331c3310005ab235ce3ca5b57566310969043e60eec3e83f4af52ccfb524513</citedby><cites>FETCH-LOGICAL-c571t-48331c3310005ab235ce3ca5b57566310969043e60eec3e83f4af52ccfb524513</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.amjmed.2011.03.009$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24483104$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21683324$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wudhikarn, Kitsada, MD</creatorcontrib><creatorcontrib>Perry, Elizabeth H., MD</creatorcontrib><creatorcontrib>Kemperman, Melissa, MPH</creatorcontrib><creatorcontrib>Jensen, Kathy A., MT(SSB)</creatorcontrib><creatorcontrib>Kline, Susan E., MD, MPH</creatorcontrib><title>Transfusion-transmitted Babesiosis in an Immunocompromised Patient: A Case Report and Review</title><title>The American journal of medicine</title><addtitle>Am J Med</addtitle><description>Abstract Babesiosis is a tick- and transfusion-borne disease caused by intraerythrocytic Babesia parasites. In 2009, a 61-year-old Minnesota woman with chronic lymphocytic leukemia and a history of recent chemotherapy and numerous blood transfusions for gastrointestinal bleeding became febrile and anemic 12 days postsplenectomy. Babesia were visualized on blood smears, confirmed by polymerase chain reaction as B. microti . She developed respiratory failure despite initiation of clindamycin and quinine, and required 12 weeks of azithromycin and atovaquone before blood smear and polymerase chain reaction findings were negative. Serologic evidence of B. microti infection was identified in 1 associated blood donor and 1 other recipient of that donor's blood. Babesia infection can be asymptomatic or cause mild to fulminant disease resulting in multiorgan failure or death. Patients with advanced age, asplenia, or other immune compromise are at risk for severe babesiosis and may require prolonged treatment to eradicate parasitemia. Incidence of transfusion-transmitted babesiosis has increased over the past decade.</description><subject>Anemia</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antimalarials - therapeutic use</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Babesia</subject><subject>Babesia microti</subject><subject>Babesiosis - drug therapy</subject><subject>Babesiosis - immunology</subject><subject>Babesiosis - transmission</subject><subject>Biological and medical sciences</subject><subject>Blood transfusions</subject><subject>Clindamycin - therapeutic use</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>General aspects</subject><subject>Hemovigilance</subject><subject>Humans</subject><subject>Immunocompromised Host - immunology</subject><subject>Immunocompromised hosts</subject><subject>Immunodeficiencies</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunopathology</subject><subject>Internal Medicine</subject><subject>Leukemia</subject><subject>Leukemia, Lymphocytic, Chronic, B-Cell - immunology</subject><subject>Leukemia, Lymphocytic, Chronic, B-Cell - therapy</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Opportunistic Infections - drug therapy</subject><subject>Opportunistic Infections - immunology</subject><subject>Opportunistic Infections - transmission</subject><subject>Parasites</subject><subject>Parasitic diseases</subject><subject>Polymerase chain reaction</subject><subject>Quinine - therapeutic use</subject><subject>Respiratory Insufficiency - immunology</subject><subject>Splenectomy</subject><subject>Transfusion Reaction</subject><subject>Transfusion-transmitted babesiosis</subject><subject>Womens health</subject><issn>0002-9343</issn><issn>1555-7162</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkstq3TAQhkVpaU7TvkEpplCysqu77S4K6aGXQCChTXcFIctjkOvLiSQ35O075pwkkE0WQiPp0-if-UXIW0YLRpn-2Bd27EdoC04ZK6goKK2fkQ1TSuUl0_w52VBKeV4LKY7Iqxh7XNJa6ZfkiDNdCcHlhvy5CnaK3RL9POVpjUefErTZF9sAbkYfMz9ldsrOxnGZZjePuzCPPiJyaZOHKX3KTrOtjZD9hN0cErIthv883LwmLzo7RHhzmI_J729fr7Y_8vOL72fb0_PcqZKlXKIW5nCgPmUbLpQD4axqVKm0xu1a11QK0BTACahEJ22nuHNdo7hUTByTk31elHa9QEwGBToYBjvBvERT1YLrstLl02QlK6mZVki-f0T28xImLGNNV3Gl6hWSe8iFOcYAndkFP9pwaxg1q0umN3uXzOqSocKgBXjt3SH30qxnd5fubEHgwwGw0dmhQ1-cjw-cxJYxunKf9xxgd7HjwUSHljhofQCXTDv7p5Q8TuAGP3l88y_cQrwvmZnIDTW_1h-1fiiGXnFZavEfM5rExw</recordid><startdate>20110901</startdate><enddate>20110901</enddate><creator>Wudhikarn, Kitsada, MD</creator><creator>Perry, Elizabeth H., MD</creator><creator>Kemperman, Melissa, MPH</creator><creator>Jensen, Kathy A., MT(SSB)</creator><creator>Kline, Susan E., MD, MPH</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Sequoia S.A</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7TO</scope><scope>7TS</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>7T2</scope><scope>7U1</scope><scope>7U2</scope><scope>C1K</scope></search><sort><creationdate>20110901</creationdate><title>Transfusion-transmitted Babesiosis in an Immunocompromised Patient: A Case Report and Review</title><author>Wudhikarn, Kitsada, MD ; Perry, Elizabeth H., MD ; Kemperman, Melissa, MPH ; Jensen, Kathy A., MT(SSB) ; Kline, Susan E., MD, MPH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c571t-48331c3310005ab235ce3ca5b57566310969043e60eec3e83f4af52ccfb524513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Anemia</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antimalarials - therapeutic use</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Babesia</topic><topic>Babesia microti</topic><topic>Babesiosis - drug therapy</topic><topic>Babesiosis - immunology</topic><topic>Babesiosis - transmission</topic><topic>Biological and medical sciences</topic><topic>Blood transfusions</topic><topic>Clindamycin - therapeutic use</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>General aspects</topic><topic>Hemovigilance</topic><topic>Humans</topic><topic>Immunocompromised Host - immunology</topic><topic>Immunocompromised hosts</topic><topic>Immunodeficiencies</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunopathology</topic><topic>Internal Medicine</topic><topic>Leukemia</topic><topic>Leukemia, Lymphocytic, Chronic, B-Cell - immunology</topic><topic>Leukemia, Lymphocytic, Chronic, B-Cell - therapy</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Opportunistic Infections - drug therapy</topic><topic>Opportunistic Infections - immunology</topic><topic>Opportunistic Infections - transmission</topic><topic>Parasites</topic><topic>Parasitic diseases</topic><topic>Polymerase chain reaction</topic><topic>Quinine - therapeutic use</topic><topic>Respiratory Insufficiency - immunology</topic><topic>Splenectomy</topic><topic>Transfusion Reaction</topic><topic>Transfusion-transmitted babesiosis</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wudhikarn, Kitsada, MD</creatorcontrib><creatorcontrib>Perry, Elizabeth H., MD</creatorcontrib><creatorcontrib>Kemperman, Melissa, MPH</creatorcontrib><creatorcontrib>Jensen, Kathy A., MT(SSB)</creatorcontrib><creatorcontrib>Kline, Susan E., MD, MPH</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Physical Education Index</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Risk Abstracts</collection><collection>Safety Science and Risk</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>The American journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wudhikarn, Kitsada, MD</au><au>Perry, Elizabeth H., MD</au><au>Kemperman, Melissa, MPH</au><au>Jensen, Kathy A., MT(SSB)</au><au>Kline, Susan E., MD, MPH</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transfusion-transmitted Babesiosis in an Immunocompromised Patient: A Case Report and Review</atitle><jtitle>The American journal of medicine</jtitle><addtitle>Am J Med</addtitle><date>2011-09-01</date><risdate>2011</risdate><volume>124</volume><issue>9</issue><spage>800</spage><epage>805</epage><pages>800-805</pages><issn>0002-9343</issn><eissn>1555-7162</eissn><coden>AJMEAZ</coden><abstract>Abstract Babesiosis is a tick- and transfusion-borne disease caused by intraerythrocytic Babesia parasites. In 2009, a 61-year-old Minnesota woman with chronic lymphocytic leukemia and a history of recent chemotherapy and numerous blood transfusions for gastrointestinal bleeding became febrile and anemic 12 days postsplenectomy. Babesia were visualized on blood smears, confirmed by polymerase chain reaction as B. microti . She developed respiratory failure despite initiation of clindamycin and quinine, and required 12 weeks of azithromycin and atovaquone before blood smear and polymerase chain reaction findings were negative. Serologic evidence of B. microti infection was identified in 1 associated blood donor and 1 other recipient of that donor's blood. Babesia infection can be asymptomatic or cause mild to fulminant disease resulting in multiorgan failure or death. Patients with advanced age, asplenia, or other immune compromise are at risk for severe babesiosis and may require prolonged treatment to eradicate parasitemia. Incidence of transfusion-transmitted babesiosis has increased over the past decade.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>21683324</pmid><doi>10.1016/j.amjmed.2011.03.009</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9343 |
ispartof | The American journal of medicine, 2011-09, Vol.124 (9), p.800-805 |
issn | 0002-9343 1555-7162 |
language | eng |
recordid | cdi_proquest_miscellaneous_893267867 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Anemia Anti-Bacterial Agents - therapeutic use Antimalarials - therapeutic use Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Babesia Babesia microti Babesiosis - drug therapy Babesiosis - immunology Babesiosis - transmission Biological and medical sciences Blood transfusions Clindamycin - therapeutic use Drug Therapy, Combination Female General aspects Hemovigilance Humans Immunocompromised Host - immunology Immunocompromised hosts Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology Internal Medicine Leukemia Leukemia, Lymphocytic, Chronic, B-Cell - immunology Leukemia, Lymphocytic, Chronic, B-Cell - therapy Medical sciences Middle Aged Opportunistic Infections - drug therapy Opportunistic Infections - immunology Opportunistic Infections - transmission Parasites Parasitic diseases Polymerase chain reaction Quinine - therapeutic use Respiratory Insufficiency - immunology Splenectomy Transfusion Reaction Transfusion-transmitted babesiosis Womens health |
title | Transfusion-transmitted Babesiosis in an Immunocompromised Patient: A Case Report and Review |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T09%3A45%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transfusion-transmitted%20Babesiosis%20in%20an%20Immunocompromised%20Patient:%20A%20Case%20Report%20and%20Review&rft.jtitle=The%20American%20journal%20of%20medicine&rft.au=Wudhikarn,%20Kitsada,%20MD&rft.date=2011-09-01&rft.volume=124&rft.issue=9&rft.spage=800&rft.epage=805&rft.pages=800-805&rft.issn=0002-9343&rft.eissn=1555-7162&rft.coden=AJMEAZ&rft_id=info:doi/10.1016/j.amjmed.2011.03.009&rft_dat=%3Cproquest_cross%3E884846165%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=893825595&rft_id=info:pmid/21683324&rft_els_id=1_s2_0_S0002934311002476&rfr_iscdi=true |